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Received July 22, 2013; accepted October 30, 2013AbstractBackground: In this study, we investigated the potential anti-inflammatory and antioxidative effects of sesamin on acute liver injury. Lead (Pb)
causes oxidative damage and enhances the effects of low-dose lipopolysaccharide (LPS), inducing acute hepatic injury in rats.
Methods: Male SpragueeDawley rats were given intraperitoneal injections of Pb acetate (5 mg/kg) and LPS (50 mg/kg) to induce liver injury,
and we tested the effects of oral administration of sesamin (10 mg/kg) on liver damage. To assess the extent of acute hepatic injury in the rats, we
measured the anti-inflammatory and antioxidant markers and relevant signaling pathways: serum aspartate aminotransferase (AST), alanine
aminotransferase (ALT), C-reactive protein (CRP), reactive oxygen species (ROS), tumor necrosis factor (TNF)-a, interleukin (IL)-1, IL-6, nitric
oxide (NO), and cyclooxygenase-2 (COX-2), inducible NO synthase (iNOS) levels, mitogen-activated protein kinases (MAPKs), c-Fos, and
GADD45b.
Results: Sesamin significantly decreased the serum AST, ALT, and CRP levels in the rat model. In the Pb and LPS-stressed rats, sesamin
administration reduced the serum levels of TNF-a, IL-1, IL-6, NO, and ROS generation, and liver tissue expressions of c-Jun N-terminal kinase
(JNK), p38 MAPK, GADD45b, COX-2, and iNOS.
Conclusion: Collectively, these results demonstrate that sesamin is associated with antioxidant and anti-inflammatory activity. The observed
effect of scavenging of ROS and NO and inhibiting the production of proinflammatory cytokines may be achieved through the suppression of
COX-2, iNOS, and MAPK pathways in the acute hepatic injury rats.
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Lead (Pb) is a persistent environment and industrial
pollutant that is known to cause oxidative damage in living
organisms.1 The International Agency for Research on Cancer
has upgraded Pb from a possible to a probable human
carcinogen.2 Low levels of Pb exposure may cause disorders
of the circulatory, renal, and nervous systems.3 Children areociation. All rights reserved.
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Fig. 1. The effect of sesamin on serum CRP levels in the acute hepatic injury
model. Experimental rats (the PL group) were given IP injections of lead
acetate (5 mg/kg) and LPS (50 mg/kg). The SA group was given oral sesamin
(10 mg/rat) in addition to the IP injections. Serum CRP levels were measured
after 4 hours of treatment. Data are expressed as the mean  SD. *p < 0.01 as
compared to the PL group. CRP ¼ C-reactive protein; IP ¼ intraperitoneal;
LPS ¼ lipopolysaccharide.
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damage caused by this metal are more severe in early devel-
opment.4,5 Additionally, coexposure to Pb and lipopolysac-
charide (LPS) causes severe hepatic injury in rats and mice.6e9
Lead synergistically increases the LPS-stimulated expres-
sion of proinflammatory cytokines, such as tumor necrosis
factor (TNF)-a and interleukin (IL)-Ib.6e9 The Pb-augmented,
LPS-stimulated TNF-a directly increases liver injury in mice,
although evidence suggests that it is produced outside the liver
in vivo.10e12 Monocytes and macrophages are the cells pri-
marily responsible for producing excess TNF-a through pro-
tein kinase C and the p42/44 mitogen-activated protein kinase
(MAPK) pathway.12,13 Lead increases LPS-induced liver
damage through protein kinase C and p42/44 MAPK modu-
lation of TNF-a, but modulation of TNF-a does not affect
nitric oxide (NO) in rats.10,13,14
Sesame oil is a potential anti-inflammatory agent that is
commonly used as an antioxidant with sesamin and sesamolin
as two major lignans. Sesamin inhibits IL-6 and TNF-a pro-
ductions from microglia under LPS stimulation.15 We have
demonstrated that inhibition of LPS-induced cytokine and
iNOS mRNA/protein by sesamin is mainly through its anti-
oxidative activity and suppression of the p38 MAPK signal
pathway.15,16 P38 MAPK is thought to mediate inflammatory
responses in various cell types and mice through the activation
of transcription factors that induce expression of inflammatory
genes.17,18 It has been shown that treatment with sesame oil
can protect mice from acute hepatic injury from Pb plus LPS
toxicity, and this protection can be attributed to the inhibition
of proinflammatory cytokines and NO.19 However, the precise
mechanism of this model by its active component is unclear.
We hypothesized that sesamin would inhibit the inflammatory
cytokines and reactive oxygen species (ROS) or reactive ni-
trogen species (RNS) production by suppression of certain
signaling pathways in the model of acute hepatic injury.
Therefore, the aim of this study was to investigate the effect
and mechanism of sesamin protection from acute hepatic
injury in rats induced by Pb and LPS.
2. Methods
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Germany). LPS (Escherichia coli 0111:B4) was obtained from
Sigma-Aldrich (St. Louis, MO, USA), and sesamin was pro-
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Fig. 2. Serum AST and ALT concentrations in response to Pb and LPS stress
and sesamin treatment. Serum AST and ALT were determined at 0 hours, 1
hour, 1.5 hours, 2 hours, 4 hours, and 6 hours after treatment. Data are pre-
sented as the mean  SD. *p < 0.01 as compared to the PL group.
ALT ¼ alanine aminotransferase; AST ¼ aspartate aminotransferase;
LPS ¼ lipopolysaccharide; Pb ¼ lead.Male SpragueeDawley rats (300e400 g) obtained from the
National Laboratory Animal Center (Taipei, Taiwan) were
maintained in the Animal Center of the Chinese Medical
University (Taichung, Taiwan). The animal studies were per-
formed following the guidelines of the Guidebook for the Care
and Use of Laboratory Animals (2002) published by the
Chinese Society of Animal Science in Taiwan. The rats weredivided into five groups and were fasted for 12 hours prior to
intraperitoneal drug administration. One control group was
given saline (blank), and the experimental groups (PL) were
given 5 mg/kg of Pb þ 50 mg/kg of LPS. The sesamin (SA)
0200
400
600
800
1000
1200
1400
1600
1800
Control
Pb+LPS
Sesamin
0 1
1.
5 2 4 6 (hour)
IL
-6
 (p
g/
m
L)
0
100
200
300
400
500
600
Control
Pb+LPS
Sesamin
IL
-1
 (p
g/
m
L)
0 1
1.
5 2 4 6 (hour)
Fig. 3. Effects of sesamin on serum IL-1 and IL-6 levels under Pb plus LPS
stress. Serum IL-1 and IL-6 were determined at 0 hours, 1 hour, 1.5 hours, 2
hours, 4 hours, and 6 hours after treatment. Data are presented as the
mean  SD. *p < 0.01 as compared to the PL group. IL ¼ interleukin;
LPS ¼ lipopolysaccharide; Pb ¼ lead.
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injection with LPS plus Pb.2.3. Biochemistry and histopathology analysisBlood samples (0.8 mL) were withdrawn by cardiopuncture
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Fig. 4. The effect of sesamin on serum TNF-a level under Pb plus LPS stress.
Data are expressed as the mean  SD. *p < 0.01 as compared to the PL group.
LPS ¼ lipopolysaccharide; TNF-a ¼ tumor necrosis factor-alpha; Pb ¼ lead.hours, and 24 hours after drug administration. The blood
samples were collected in microtubes and centrifuged at
10,000g for 15 minutes at 4C to isolate the serum. Serum
cytokine levels were measured at 0 hour, 1.5 hours, 3 hours,
and 6 hours after treatments. TNF-a, IL-1b, and IL-6 levels in
the serum were measured using enzyme-linked immunosor-
bent assay (ELISA) kits (R&D Systems, Minneapolis, MN,
USA) by measuring A450 nm in a microplate reader (Model,
TECAN, Salzburg, Austria). ELISA results have a detection
limit of 32.5 pg/mL. Serum C-reactive protein (CRP) level
was measured with a rat CRP ELISA kit (Immunology Con-
sultants Laboratory, Portland, OR, USA). The activities of
iNOS and glyceraldehyde-3-phosphate dehydrogenase in leu-
kocytes and liver tissue were examined 6 hours after treatment.
In addition, TNF-a, IL-1b, nitrite, and iNOS expression levels
in hepatic tissue were assessed 6 hours after treatment as
described in the following section. Liver tissues were fixed
with a 10% formaldehyde solution overnight and H&E (he-
matoxylin and eosin) stained. Hepatic function was assessed
by measuring serum alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) with an automatic blood
analyzer (Hitachi High-Technologies, Tokyo, Japan).2.4. Measuring TNF-a, IL-1b, and IL-6 levels in the
liver tissueLiver tissue was homogenized in deionized water (1:10;
weight/volume) and centrifuged at 3000g for 10 minutes at
4C. The TNF-a, IL-1b, and IL-6 levels in the tissue super-
natant were determined using ELISA kits (R&D Systems).
Protein concentration (pg/mg) in the liver tissue was deter-
mined using a dye-based protein assay (Bio-Rad Laboratories,
Hercules, CA, USA).2.5. NO assayNitrite was measured as NO using the Griess test. Briefly, a
serum sample was reacted with an equal volume of Griess0
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Fig. 5. Effect of sesamin on serum nitric oxide level in rats with and without
Pb plus LPS stress. Data are expressed as the mean  SD. *p < 0.01 as
compared to the PL group. LPS ¼ lipopolysaccharide; Pb ¼ lead.
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Fig. 6. The effect of sesamin on serum ROS level under Pb plus LPS stress.
Data are expressed as the mean  SD. *p < 0.01 as compared to the PL group.
LPS ¼ lipopolysaccharide; ROS ¼ reactive oxygen species; Pb ¼ lead.
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amide (1:1) in H3PO4] in 96-well plates for 10 minutes. The
absorbance at 540 nm was measured in a microplate reader.2.6. ROS generationROS was measured with 20,70-dichlorodihydrofluorescein
diacetate (H2DCF-DA). Additionally, H2DCF-DA wasFig. 7. Protective effect of sesamin on Pb plus lipopolysaccharide (LPS)-induced he
control group; (B) the PL group, given 5 mg/kg Pb and 50 mg/g LPS; and (C) the S
treatment. The photographs show liver sections at 400 magnification. Spotty nec
groups. Pb ¼ lead; PL group ¼ experimental group; SA group ¼ sesamin group.dissolved in methanol and deacetylated in serum mixed with
10 mM H2DCF for 10 minutes in the dark. The reaction so-
lution was plated in 96-well plates and monitored on a Fluo-
roskan Ascent Fluorometer (Labsystems Oy, Helsinki,
Finland) using an excitation wave length of 485 nm and an
emission wave length of 538 nm.2.7. Western blottingRat liver cell-line (clone-9 cells) or liver tissues were ho-
mogenized in ice-cold lysis buffer (1:10, weight/volume)
containing 20 mmol/L 4-(2-hydroxyethyl)-1-piperazine ethane
sulfonic acid (pH 7.2), 1% Triton X-100, 10% glycerol, 1 mM
PMSF (phenylmethylsulfonyl fluoride), 10 mg/mL leupeptin,
and 10 mg/mL aprotinin. This solution was centrifuged at
10,000g for 30 minutes at 4C. Thereafter, 50 mg of protein
was run on an 8% or 10% sodium dodecyl sulfa-
teepolyacrylamide gel and transferred onto nitrocellulose
membranes (NEN Life Sciences, Boston, MA, USA) at 1.2 A
for 3 hours. The membranes were blocked in 5% milk in Tris
buffer saline with Tween-20. The membrane was then incu-
bated with polyclonal rabbit iNOS antibody (BD Biosciences,
San Diego, CA, USA) and diluted 1:1000 in blocking buffer.
Membranes were incubated with secondary anti-rabbit IgG
conjugated to alkaline phosphatase (1:3000; Jackson
ImmunoResearch, Philadelphia, PA, USA) and detected with
alkaline phosphatase substrate solution (5-bromo-4-chloro-3-patic injury. Histopathology of liver slices from rats from: (A) the no treatment
A group, PL treatment supplemented with 10 mg sesame/rat for 6 hours after
rosis and hydropic degeneration was more severe in PL than in control or SA
231H.-M. Chiang et al. / Journal of the Chinese Medical Association 77 (2014) 227e233indolyl-phosphate/nitroblue tetrazolium; Kirkegaard & Perry,
Baltimore, MD, USA).2.8. Statistical analysisAll data are expressed as mean  SD. For single variable
comparisons, Student t test was used. For multiple variable
comparisons, data were analyzed with one-way analysis of
variance using Dunnett’s test. A p value of <0.05 or p < 0.01
was considered significant.
3. Results
Studies show that antioxidants ameliorate acute hepatic
injury in various animal models,20e22 and that sesame oil
protects mice from acute hepatic injury through the inhibition
of cytokines and NO production.19 These results show that
sesamin, an active component of sesame oil, relieved acute
hepatic injury in rats under Pb þ LPS stress. Sesamin reduced
serum CRP, ALT, and AST levels in rats after an injection with
Pb þ LPS (Figs. 1 and 2). Serum levels of liver enzymes such
as ALT and AST reflect liver function and hepatocyteFig. 8. Effect of sesamin on Pb plus LPS-induced signaling pathways. The activa
pressions were assayed in Sprague-Dawley rats and clone-9 cells, respectively, in viv
sesamin/rat and injected with 5 mg/kg Pb and 50 mg/kg LPS for 6 hours (A), and
sesamin for 10 minutes (B). Data are expressed as the mean  SD. *p < 0.01
iNOS ¼ inducible NO synthase; LPS ¼ lipopolysaccharide; MAPKs ¼ mitogen-aintegrity.23 Levels of ALT and AST increased with Pb þ LPS-
induced liver injury but were lower with sesamin treatment,
suggesting that sesamin may protect rats from Pb þ LPS liver
injury (Fig. 2; p < 0.05 and p < 0.05 vs. the PL group). Our
results showed that sesamin could protect from liver injury by
attenuating the increased serum IL-1, IL-6 (Fig. 3; p < 0.0001)
and TNF-a and nitrite (Figs. 4 and 5; p < 0.005 vs. the PL
group) in the PL-induced rats. These results are consistent
with the previous finding that reduction of TNF-a, IL-1, and
NO has a protective effect against Pb þ LPS-induced liver
injury in animals.10,13,14
ROS and RNS are necessary for normal physiological
functions but also contribute to liver injury.24 We found that
sesamin was able to scavenge 25e44% of PL-induced serum
ROS and nitrite (Figs. 5 and 6; p < 0.005 and p < 0.005 vs. the
PL group, respectively). Because ROS and RNS signals can
trigger the intrinsic apoptosis pathway,25 sesamin might
reduce the apoptosis of hepatocytes under Pb plus LPS stress
by scavenging these free radicals. Cell atrophy, irregular
arrangement with degeneration, and spotty necrosis were
observed in the liver section of the PL group (Fig. 7B), but not
in the control group (Fig. 7A). The SA group (Fig. 7C) showedtion of phospho-MAPKs, COX-2, iNOS, CHOP, c-FOS, and GADD45b ex-
o and in vitro. Livers were obtained from rats treated or not treated with 10 mg
Clone-9 cells were treated with 1 mg/mL LPS plus 100 mg/mL Pb and 50 mM
as compared to the PL group of rats or cells. COX-2 ¼ cyclooxygenase-2;
ctivated protein kinases.
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200 microscopic fields of the liver section.
The effects of sesamin on PL-induced signaling pathways
were further examined by Western blot assay (Fig. 8A). Ses-
amin reduced expression of the following proteins: JNK
(53  9%), ERK (36  6%), p38 (28  7%) MAPKs, COX-2
(50  6%), iNOS (48  6%), CHOP (15  4%), c-FOS
(8  3%), and GADD45b (59  6%), respectively, to the PL-
induced SD rats (P < 0.01). Similarly, sesamin also sup-
pressed Pb þ LPS-induced phospho-MAPKs, COX-2, iNOS,
CHOP, c-FOS, and GADD45b expression in clone-9 cells
(Fig. 8B). However, c-FOS was not affected by sesamin in
clone-9 cells (data not shown).
4. Discussion
The Pb þ LPS model is a relevant animal model for
cytokine-associated hepatic injury.26,27 Several studies have
shown that TNF-a is a critical regulator of hepatocyte physi-
ology in a variety of pathophysiological conditions,28 such as
viral hepatitis,29 fulminant hepatic failure,30 and alcoholic
hepatitis.31 In the present study, sesamin was found to lower
PL-induced TNF-a production in both serum and liver tissue
(data not shown). The sesamin-induced reduction of TNF-a
could be due to either a decreased production or an increased
clearance of TNF-a, and future studies will provide additional
clarification. A previous study showed that NO induces TNF-a
production in Pb þ LPS-treated rats.8 In the present study, the
reduced TNF-a, IL-1b, IL-6, and NO levels in sesamin-treated
model rats suggested that sesamin could be used for protection
from acute hepatic injury.
Sesamin is the major lignan from sesame seeds that has
antioxidative and anti-inflammatory effects.15,16 An NO in-
hibitor protects against Pb þ LPS-treated liver dysfunction
by blocking TNF-a expression.8 Therefore, sesamin could
be a useful addition to an NO inhibitor for reducing acute
hepatic toxicity in Pb LPS-treated mice. Because sesamin
can protect against LPS- and oxidative-stressed injuries,15,32
it might also reduce ROS generation in this model. The
result showed that the protective effect of sesamin on acute
hepatic injury could be attributed to an inhibition of ROS
and RNS through suppressing the PL-induced JNK, ERK,
p38 MAPKs, COX-2, iNOS, CHOP, and GADD45b
signaling pathways. Recently, T-5224, a selective inhibitor
of c-Fos/activator protein (AP)-1, has been shown to protect
against LPS-induced liver injury by reducing the serum
levels of TNF-a, HMGB1, ALT/AST, liver levels of MIP-1a
and MCP-1, and overall lethality.33 It has already been
proposed that CHOP and GADD45b expression are
increased during acute liver damage.34,35 However, c-FOS
was not affected by sesamin in clone-9 cells.
In conclusion, the presented data show that sesamin
effectively ameliorates Pb and LPS-induced acute hepatic
injury by inhibition of proinflammatory cytokines and NO.
The inhibition of acute hepatic injury was mainly through the
suppression of several signaling pathways such as JNK and
p38 MAPKs, COX-2, iNOS, CHOP, and GADD45b.Acknowledgments
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